Nipah Protein Structure Revealed

The structure of a key protein of the deadly virus could serve as a stepping stone to antiviral therapy.

Written byJef Akst
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

A transmission electron micrograph of Nipah virions isolated from a patient's cerebrospinal fluidWIKIMEDIA, CDCThe Nipah virus phosphoprotein, P, plays a key role in viral replication. Therefore, understanding its structure may shed light on ways to disrupt the viral life cycle. “If you can prevent the virus from making more RNA, then it can’t replicate, which is a good strategy for developing antiviral medications,” Jessica Bruhn, a graduate student in Erica Ollmann Saphire’s lab at Scripps Research Institute in La Jolla, California, said in a press release.

With this in mind, Bruhn, Saphire, and colleagues subjected the protein to X-ray crystallography, observing diffraction patterns that revealed its shape: “a long, parallel, tetrameric, coiled coil with a small, α-helical cap structure,” according the paper published in the December issue of the Journal of Virology. Interestingly, this shape is highly similar to the P protein structure of the sendai, measles, and mumps paramyxoviruses, all of which are long, tetrameric coils, despite the fact that these viruses share little sequence identity with one another or with Nipah.

“It was surprising to us that this structure is so similar to those from measles and mumps viruses, even though they are only 5 [percent] to 26 percent identical in sequence,” Bruhn said in the release. The results ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies